Archive - January 2023
UK biotech sees worst funding downturn since 2012
J&J copay lawsuit against drug benefit firm gets green light
FDA refuses to regulate CBD, calling on Congress to take charge
FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants
Ipsen reports CHMP negative review for use of palovarotene in EU
IsoChemiX develop molecules to speed up R&D process
Experts Differ on Proposed Lagos General Hospitals Upgrade
FDA pulls AZ’s Evusheld for COVID, citing lack of efficacy